XML 33 R22.htm IDEA: XBRL DOCUMENT v3.24.3
NET INCOME PER SHARE
9 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
NET INCOME PER SHARE NET INCOME PER SHARE
Basic net income per share is computed by dividing net income by the weighted average number of shares of common stock outstanding during the period. Diluted net income per share is computed in a similar manner, but it also includes the effect of potential common shares outstanding during the period, when dilutive.
The following table presents the computation of basic and diluted net income per share for the periods presented:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2024202320242023
(In thousands, except per share data)
Numerator:
Net income$45,762 $113,953 $40,498 $418,017 
Convertible senior notes interest and financing costs, net of tax618 1,655 — 4,910 
Adjusted net income$46,380 $115,608 $40,498 $422,927 
Denominator:
Shares used in basic per share amounts:
Weighted average common shares outstanding135,329 136,165 135,621 136,491 
Shares used in diluted per share amounts:
Weighted average common shares outstanding used for basic calculation135,329 136,165 135,621 136,491 
Effect of dilutive securities:
Employee stock-based awards456 1,307 528 1,907 
Notes due 2023— 750 — 850 
Notes due 2025— 1,253 — 1,253 
2025 Warrants
54 313 87 505 
Notes due 20262,057 2,057 — 2,057 
Notes due 20282,018 2,018 — 2,018 
Weighted average common shares outstanding for diluted calculation139,914 143,863 136,236 145,081 
Basic and diluted net income per share
Net income per share, basic$0.34 $0.84 $0.30 $3.06 
Net income per share, diluted$0.33 $0.80 $0.30 $2.92 
Diluted earnings per share for the three and nine months ended September 30, 2024 includes the dilutive effect of potentially dilutive common shares by application of the treasury stock method for stock options, RSUs, PSUs, ESPP, the 2025 Warrants, and includes potentially dilutive common shares by application of the if-converted method for the Notes due 2025, Notes due 2026 and Notes due 2028. Potentially dilutive common shares for the three and nine months ended September 30, 2023 include stock options, RSUs, PSUs, shares to be purchased under the ESPP, Notes due 2025, Notes due 2026, Notes due 2028, Notes due 2023 and the 2025 Warrants. To the extent these potential common shares are antidilutive, they are excluded from the calculation of diluted net income per share.
Further, the Company under the relevant sections of the indentures, irrevocably may elect to settle principal in cash and any excess in cash or shares of the Company’s common stock for the Notes due 2025, Notes due 2026 and Notes due 2028. If and when the Company makes such election, there will be no adjustment to the net income and the Company will use the average share price for the period to determine the potential number of shares to be issued based upon assumed conversion to be included in the diluted share count.
The following outstanding shares of common stock equivalents were excluded from the calculation of the diluted net income per share attributable to common stockholders because their effect would have been antidilutive:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2024202320242023
(In thousands)
Employee stock-based awards1,330 1,533 1,396 1,067 
Notes due 2028— — 2,018 — 
2028 Warrants5,170 3,620 4,970 2,468 
Notes due 2026— — 2,057 — 
2026 Warrants5,269 3,689 5,065 2,515 
Notes due 20251,253 — 1,253 — 
Total13,022 8,842 16,759 6,050